Sanochemia Pharmazeutika AG (SAC)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Sanochemia Pharmazeutika AG (SAC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011145
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio includes radiological products including an array of x-ray imaging agents and the MRT imaging agent; and veterinary pharmaceuticals. It also offers synthesis of active pharmaceutical substances (APIs), drug formulation and pharmaceutical production and contract research. Apart from Austria, Sanochemia offers its products in Remaining Europe, Asia, MENA (Middle East and North Africa), Commonwealth of Independent States (CIS) countries and rest of the world. The company has sales offices in Switzerland, Germany, the UK and the US. Sanochemia is headquartered in Vienna, Austria.

Sanochemia Pharmazeutika AG (SAC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanochemia Pharmazeutika AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Sanochemia Pharmazeutika AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Sanochemia Pharmazeutika AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Sanochemia Pharmazeutika AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Sanochemia Pharmazeutika AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Sanochemia Pharmazeutika AG, Medical Equipment, Deal Details 10
Partnerships 10
Link Healthcare Enters Into Agreement With Sanochemia Pharmazeutika For Secrelux 10
Sanochemia Pharmazeutika Enters into Licensing Agreement with Pharma Company 11
Equity Offering 12
Sanochemia Pharmazeutika Completes Private Placement Of Shares For US$6.3 Million 12
Sanochemia Pharmazeutika AG – Key Competitors 13
Sanochemia Pharmazeutika AG – Key Employees 14
Sanochemia Pharmazeutika AG – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Sanochemia Pharmazeutika AG, Medical Equipment, Key Facts, 2016 2
Sanochemia Pharmazeutika AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sanochemia Pharmazeutika AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Sanochemia Pharmazeutika AG, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Sanochemia Pharmazeutika AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Sanochemia Pharmazeutika AG, Deals By Market, 2011 to YTD 2017 8
Sanochemia Pharmazeutika AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Link Healthcare Enters Into Agreement With Sanochemia Pharmazeutika For Secrelux 10
Sanochemia Pharmazeutika Enters into Licensing Agreement with Pharma Company 11
Sanochemia Pharmazeutika Completes Private Placement Of Shares For US$6.3 Million 12
Sanochemia Pharmazeutika AG, Key Competitors 13
Sanochemia Pharmazeutika AG, Key Employees 14
Sanochemia Pharmazeutika AG, Other Locations 15
Sanochemia Pharmazeutika AG, Subsidiaries 15

★海外企業調査レポート[Sanochemia Pharmazeutika AG (SAC)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Linde AG (LIN):企業の財務・戦略的SWOT分析
    Linde AG (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Entergy New Orleans Inc:電力:M&Aディール及び事業提携情報
    Summary Entergy New Orleans Inc (Entergy) a subsidiary of Entergy Corporation is an electric utility company that offers power distribution services. The company provides electric distribution, account management, payment options and services, community services, business and economic development. I …
  • Shanghai Pudong Development Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Pharma Mar SA (PHM)-製薬・医療分野:企業M&A・提携分析
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • ITC Ltd:戦略・SWOT・企業財務分析
    ITC Ltd - Strategy, SWOT and Corporate Finance Report Summary ITC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Kamada Ltd (KMDA):企業の財務・戦略的SWOT分析
    Kamada Ltd (KMDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aegean Marine Petroleum Network Inc (ANW):石油・ガス:M&Aディール及び事業提携情報
    Summary Aegean Marine Petroleum Network Inc (AMPL) is a provider of marine fuel logistics services. The company markets and offers refined marine fuels and lubricants to ships. Its lubricants include marine fuels, mineral, cargo trading, marine lubricants, synthetic and next generation bio degradabl …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Pasteur Institute is a non-profit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structura …
  • Oncolytics Biotech Inc (ONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • University of Toronto-製薬・医療分野:企業M&A・提携分析
    Summary University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continu …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • American Axle & Manufacturing Holdings, Inc.:企業の戦略・SWOT・財務情報
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • China Yurun Food Group Limited:企業の戦略・SWOT・財務情報
    China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lantern Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lantern Pharma Inc (Lantern Pharma) is a clinical stage pharmaceutical company that discovers and develops therapies for various cancer types. The company’s pipeline products Irofulven-1 and Irofulven-2 are non-hormone, non-chemotherapy, next-generation DNA damage repair inhibitors. Its othe …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆